Immune heterogeneity and therapeutic resistance in gynecological malignancies - Top-Institutions - MDSpire

Immune heterogeneity and therapeutic resistance in gynecological malignancies

  • By

  • Mengyi Zhang

  • Binhan Guo

  • June 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Adelaide University
    Adelaide University

    Adelaide, SA

    Key Differentiators

    • Oncology

  • #2

    Fred Hutchinson Cancer Research Center
    Fred Hutchinson Cancer Research Center

    Seattle, WA

    Key Differentiators

    • Oncology

  • #3

    New York University (NYU) Langone Health
    New York University (NYU) Langone Health

    New York, NY

    Key Differentiators

    • Oncology

  • #4

    Roswell Park Comprehensive Cancer Center
    Roswell Park Comprehensive Cancer Center

    Buffalo, NY

    Key Differentiators

    • Oncology

  • #5

    University of Virginia Cancer Center
    University of Virginia Cancer Center

    Charlottesville, VA

    Key Differentiators

    • Oncology

Original Source(s)

Immune heterogeneity and therapeutic resistance in gynecological malignancies

  • by Mengyi Zhang, Binhan Guo

  • June 22, 2026

Related Content

Prostatic incidental uptake on PET/CT: an updated systematic review and meta-analysis of prevalence and malignancy risk

cfDNA’s Big Moment Has Arrived

Experts explore the promise, pitfalls, and future of cfDNA testing in modern laboratory medicine

Past present and future of radiosensitization in cervical cancer